Pharmacy and healthcare staff should be aware and ask patients if they take any other medication when prescribing, selling or administering alternative medicines such as Chinese wolfberry, chamomile tea, cannabis, cranberry, chitosan, green tea, Ginkgo biloba, ginger, spinach, St. John’s Wort, sushi and smoking tobacco. The concomitant use of the aforementioned therapies, teas, sushi and smoking has shown to increase the risk of bleeding taken with warfarin.
The British Journal of Clinical Pharmacology has issued guidance on risks of taking alternative therapies and warfarin
by Jackie (née Heneghan) Peck | Jul 20, 2020 | Blog
Recent Posts
Testimonials
Having just completed the very informative API and Clinical Trail course (thank you Shankar) I was reminded of the traps we can fall into whereby we try to keep ourselves in our little boxes. At the MHRA symposium, I have heard several times comments such as:- “no, I’m not doing the GMP day as it’s not relevant to me” or “GDP? Oh, that doesn’t apply to us as we are manufacturers”. I am sure these comments were made well out of the earshot of MHRA personnel and on the face of it see… Read more
API and Clinical Trails Training
Kim was helpful at answering all my questions and advise on how to do things independently or with the help of PCL.
Testimonial from a Pharmacist Trainee
Very informative. Thank you.
Katie Wenlock - Link Medical
Again, I stress how much I appreciate all your help, both today and through the whole journey of us striving to obtain our WDA(H).
Michael OgundeleAderemi Healthcare Ltd.
The course is very informative and comprehensive which covers all aspects of EU GDP guidelines.
Haidar Al-Bukhari
“Index the presentation to be able to reference quicker – detailed key acronyms. Good course, very enlightening for understanding and questioning current processes within our company.” Craig Buzzard – Course Rating 9/10
GDP & RP Training
Pharmacy Consulting have provided our business with excellent support, advice and training with regard to obtaining Wholesale Dealers Authorisation following the implementation of European Commission Guidelines of 5 November 2013 on Good Distribution Practice, 2013/C 343/01. I would like to personally thank Dawn and her team for her personal assistance in securing the authorisation.
Testimonial from Link Medical Limited, Bramshill
I want to thank you again for your successful presentation made in London to our Pharma Group Europe conference. Your detailed explanations for all the delegates were extremely interesting and enlightening. Our international participants from Germany, Austria, Switzerland and Romania expressed their praise and encouragement. Zdenek Schmittz- Pharma Group Europe
Testimonial from Zdenek Schmittz- Pharma Group Europe
“MHRA GDP guidelines are numerous and specific and potentially serious if not followed. The training went through each point in a common sense way, so the guidelines have appeared far more admirable and attainable.” Philip Hodgkinson – Course Rating 10/10
GDP Training
It was an absolute pleasure to meet with you and we are delighted given the extent of your contribution. There were many positive comments concerning your overall contribution. And as you are aware the workshops were exceptionally interesting for the audience. But also many colleagues made direct comments concerning your presentation which was rated as a highly clear and concise.
Ash Kay